...
首页> 外文期刊>Frontiers in Pharmacology >Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis
【24h】

Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis

机译:长非编码RNA Rian和Miat介导肾纤维化中成肌纤维细胞形成。

获取原文
           

摘要

There is an increasing prevalence of chronic kidney disease (CKD), which associates with the development of interstitial fibrosis. Pericytes (perivascular fibroblasts) provide a major source of α-SMA-positive myofibroblasts that are responsible for the excessive deposition of extracellular matrix. In order to identify pericyte long non-coding RNAs (lncRNAs) that could serve as a target to decrease myofibroblast formation and counteract the progression of kidney fibrosis we employed two models of experimental kidney injury, one focused on kidney fibrosis (unilateral ureteral obstruction; UUO), and one focused on acute kidney injury that yields kidney fibrosis in the longer term (unilateral ischemia-reperfusion injury; IRI). This was performed in FoxD1-GC;tdTomato stromal cell reporter mice that allowed pericyte fate tracing. Tomato red-positive FoxD1-derivative cells of control and injured kidneys were FACS-sorted and used for lncRNA and mRNA profiling yielding a distinctive transcriptional signature of pericytes and myofibroblasts with 244 and 586 differentially expressed lncRNAs (&twofold, P & 0.05), in the UUO and IRI models, respectively. Next, we selected two differentially expressed and conserved lncRNAs, Rian (RNA imprinted and accumulated in nucleus) and Miat (Myocardial infarction associated transcript), and explored their potential regulatory role in myofibroblast formation through knockdown of their function with gapmers. While Miat was upregulated in myofibroblasts of UUO and IRI in mice, gapmer silencing of Miat attenuated myofibroblast formation as evidenced by decreased expression of α-SMA , col1α1 , SMAD2 , and SMAD3 , as well as decreased α-SMA and pro-collagen-1α1 protein levels. In contrast, silencing Rian, which was found to be downregulated in kidney myofibroblast after IRI and UUO, resulted in increased myofibroblast formation. In addition, we found microRNAs that were previously linked to Miat (miR-150) and Rian (14q32 miRNA cluster), to be dysregulated in the FoxD1-derivative cells, suggesting a possible interaction between miRNAs and these lncRNAs in myofibroblast formation. Taken together, lncRNAs play a regulatory role in myofibroblast formation, possibly through interacting with miRNA regulation, implicating that understanding their biology and their modulation may have the potential to counteract the development of renal fibrosis.
机译:慢性肾脏病(CKD)的患病率上升,与间质纤维化的发展有关。周细胞(血管周成纤维细胞)提供了α-SMA阳性肌成纤维细胞的主要来源,这是细胞外基质过度沉积的原因。为了鉴定可以用作减少成肌纤维细胞形成并抵消肾脏纤维化进程的靶标的周细胞长非编码RNA(lncRNA),我们采用了两种实验性肾脏损伤模型,一种针对肾脏纤维化(单侧输尿管阻塞; UUO) ),重点是从长期来看会导致肾脏纤维化的急性肾脏损伤(单侧缺血再灌注损伤; IRI)。这在允许周细胞命运追踪的FoxD1-GC; tdTomato基质细胞报告基因小鼠中进行。将对照肾和受伤肾脏的番茄红阳性FoxD1衍生细胞进行FACS分选,并用于lncRNA和mRNA谱分析,产生具有244和586个差异表达的lncRNA的周细胞和成肌纤维细胞的独特转录特征(>两倍,P <0.05)。 ,分别在UUO和IRI模型中。接下来,我们选择了两个差异表达和保守的lncRNA,Rian(在核中印记并积累的RNA)和Miat(心肌梗塞相关的转录本),并通过用间隔体敲低它们的功能探讨了它们在成肌纤维细胞形成中的潜在调控作用。虽然Miat在小鼠UUO和IRI的成肌纤维细胞中上调,但Miat的间隔体沉默可减弱成肌纤维细胞的形成,这由α-SMA,col1α1,SMAD2和SMAD3的表达降低,以及α-SMA和pro-collagen-1α1的降低所证明蛋白质水平。相反,沉默Rian(在IRI和UUO之后在肾脏成纤维细胞中被下调)导致成肌纤维形成增加。此外,我们发现先前与Miat(miR-150)和Rian(14q32 miRNA簇)连接的microRNA在FoxD1衍生细胞中失调,提示在成纤维细胞形成中miRNA与这些lncRNA之间可能存在相互作用。综上所述,lncRNAs可能通过与miRNA调控相互作用,在成肌纤维细胞形成中发挥调控作用,这意味着了解其生物学特性及其调控机制可能会抵消肾纤维化的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号